Literature DB >> 10527858

Novel association of the src family kinases, hck and c-fgr, with CCR3 receptor stimulation: A possible mechanism for eotaxin-induced human eosinophil chemotaxis.

A El-Shazly1, N Yamaguchi, K Masuyama, T Suda, T Ishikawa.   

Abstract

The chemokine eotaxin is a potent and relatively eosinophil-specific chemoattractant implicated in the cell migration to inflammatory sites in allergic diseases. Eotaxin exerts its activity solely through the CCR3 receptor, but the signaling pathways are poorly defined. In this study, we show that eotaxin induces an increase in tyrosine phosphorylation of multiple cellular proteins in normal human eosinophils. Eotaxin-dependent tyrosine phosphorylation was detected 1 min after stimulation and increased for at least 15 min with kinetics similar to those of eotaxin-induced cell shape changes. Herbimycin A, a tyrosine kinase inhibitor, blocked both eotaxin-induced tyrosine phosphorylation and cell shape changes as well as chemotaxis. Immunofluorescence microscopy analyses showed that eotaxin-induced cell shape changes were accompanied by redistribution of tyrosine-phosphorylated proteins and F-actin reorganization that were sensitive to herbimycin A. Coimmunoprecipitation studies revealed that binding of eotaxin to CCR3 greatly enhanced association of the Src family kinases, Hck and c-Fgr, with CCR3 after internalization of CCR3. These results may indicate that recruitment of Hck and c-Fgr to CCR3 in a compartment triggers tyrosine phosphorylation, leading to rapid cell shape changes required for cell migration. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527858     DOI: 10.1006/bbrc.1999.1379

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Chemoattractant-induced signaling via the Ras-ERK and PI3K-Akt networks, along with leukotriene C4 release, is dependent on the tyrosine kinase Lyn in IL-5- and IL-3-primed human blood eosinophils.

Authors:  Yiming Zhu; Paul J Bertics
Journal:  J Immunol       Date:  2010-11-24       Impact factor: 5.422

2.  Epstein-Barr Virus-induced Gene 2 Mediates Allergen-induced Leukocyte Migration into Airways.

Authors:  Zhong-Jian Shen; Jie Hu; Venkatesh P Kashi; Elizabeth A Kelly; Loren C Denlinger; Kevan Lutchman; Jeffrey G McDonald; Nizar N Jarjour; James S Malter
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

3.  The Src family kinases Hck and Fgr regulate neutrophil responses to N-formyl-methionyl-leucyl-phenylalanine.

Authors:  Laura Fumagalli; Hong Zhang; Anna Baruzzi; Clifford A Lowell; Giorgio Berton
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

4.  Activation of RBL-2H3 mast cells is dependent on tyrosine phosphorylation of phospholipase D2 by Fyn and Fgr.

Authors:  Wahn Soo Choi; Takaaki Hiragun; Jun Ho Lee; Young Mi Kim; Hyoung-Pyo Kim; Ahmed Chahdi; Erk Her; Jeung Whan Han; Michael A Beaven
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

5.  A parallel signal-transduction pathway for eotaxin- and interleukin-5-induced eosinophil shape change.

Authors:  Eun Nam Choi; Moon Kyung Choi; Choon-Sik Park; Il Yup Chung
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

6.  A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils.

Authors:  Ariel Munitz; Melissa L McBride; Joshua S Bernstein; Marc E Rothenberg
Journal:  Blood       Date:  2008-03-03       Impact factor: 22.113

Review 7.  Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.

Authors:  Ashleigh R Poh; Robert J J O'Donoghue; Matthias Ernst
Journal:  Oncotarget       Date:  2015-06-30

8.  Gene-specific sex effects on eosinophil infiltration in leishmaniasis.

Authors:  Martina Slapničková; Valeriya Volkova; Marie Čepičková; Tatyana Kobets; Matyáš Šíma; Milena Svobodová; Peter Demant; Marie Lipoldová
Journal:  Biol Sex Differ       Date:  2016-11-22       Impact factor: 5.027

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.